Value proposition

Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections

Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR).

Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy